COVID-19 Impact on Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Monotherapy
  • 1.4.3 Combination Therapy
• 1.5 Market by Application
  • 1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hematologic Malignancies
  • 1.5.3 Solid Malignancies
• 1.6 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Immunotherapy Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the CAR T-Cell Immunotherapy Industry
    • 1.6.1.1 CAR T-Cell Immunotherapy Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for CAR T-Cell Immunotherapy Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 CAR T-Cell Immunotherapy Market Perspective (2015-2026)
• 2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
  • 2.2.1 CAR T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 CAR T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 CAR T-Cell Immunotherapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key CAR T-Cell Immunotherapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top CAR T-Cell Immunotherapy Players by Market Size
  • 3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2015-2020)
  • 3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global CAR T-Cell Immunotherapy Market Concentration Ratio
  • 3.2.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2019
• 3.3 CAR T-Cell Immunotherapy Key Players Head office and Area Served
• 3.4 Key Players CAR T-Cell Immunotherapy Product Solution and Service
• 3.5 Date of Enter into CAR T-Cell Immunotherapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
• 4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)

5 CAR T-Cell Immunotherapy Breakdown Data by Application (2015-2026)

• 5.1 Global CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
• 5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America CAR T-Cell Immunotherapy Market Size (2015-2020)
• 6.2 CAR T-Cell Immunotherapy Key Players in North America (2019-2020)
• 6.3 North America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
• 6.4 North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe CAR T-Cell Immunotherapy Market Size (2015-2020)
• 7.2 CAR T-Cell Immunotherapy Key Players in Europe (2019-2020)
• 7.3 Europe CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
• 7.4 Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

8 China

• 8.1 China CAR T-Cell Immunotherapy Market Size (2015-2020)
• 8.2 CAR T-Cell Immunotherapy Key Players in China (2019-2020)
• 8.3 China CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
• 8.4 China CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan CAR T-Cell Immunotherapy Market Size (2015-2020)
• 9.2 CAR T-Cell Immunotherapy Key Players in Japan (2019-2020)
• 9.3 Japan CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
• 9.4 Japan CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2015-2020)
• 10.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

11 India

• 11.1 India CAR T-Cell Immunotherapy Market Size (2015-2020)
• 11.2 CAR T-Cell Immunotherapy Key Players in India (2019-2020)
• 11.3 India CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
• 11.4 India CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America CAR T-Cell Immunotherapy Market Size (2015-2020)
• 12.2 CAR T-Cell Immunotherapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
• 12.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AbbVie
  • 13.1.1 AbbVie Company Details
  • 13.1.2 AbbVie Business Overview and Its Total Revenue
  • 13.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
  • 13.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2015-2020))
  • 13.1.5 AbbVie Recent Development
• 13.2 Celgene
  • 13.2.1 Celgene Company Details
  • 13.2.2 Celgene Business Overview and Its Total Revenue
  • 13.2.3 Celgene CAR T-Cell Immunotherapy Introduction
  • 13.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.2.5 Celgene Recent Development
• 13.3 Kite Pharma
  • 13.3.1 Kite Pharma Company Details
  • 13.3.2 Kite Pharma Business Overview and Its Total Revenue
  • 13.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
  • 13.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.3.5 Kite Pharma Recent Development
• 13.4 Oxford BioMedica
  • 13.4.1 Oxford BioMedica Company Details
  • 13.4.2 Oxford BioMedica Business Overview and Its Total Revenue
  • 13.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
  • 13.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.4.5 Oxford BioMedica Recent Development
• 13.5 Novartis
  • 13.5.1 Novartis Company Details
  • 13.5.2 Novartis Business Overview and Its Total Revenue
  • 13.5.3 Novartis CAR T-Cell Immunotherapy Introduction
  • 13.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.5.5 Novartis Recent Development
• 13.6 Gilead
  • 13.6.1 Gilead Company Details
  • 13.6.2 Gilead Business Overview and Its Total Revenue
  • 13.6.3 Gilead CAR T-Cell Immunotherapy Introduction
  • 13.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.6.5 Gilead Recent Development
• 13.7 Pfizer
  • 13.7.1 Pfizer Company Details
  • 13.7.2 Pfizer Business Overview and Its Total Revenue
  • 13.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
  • 13.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.7.5 Pfizer Recent Development
• 13.8 Cellectis
  • 13.8.1 Cellectis Company Details
  • 13.8.2 Cellectis Business Overview and Its Total Revenue
  • 13.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
  • 13.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.8.5 Cellectis Recent Development
• 13.9 Bellicum
  • 13.9.1 Bellicum Company Details
  • 13.9.2 Bellicum Business Overview and Its Total Revenue
  • 13.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
  • 13.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.9.5 Bellicum Recent Development
• 13.10 Mustang Bio
  • 13.10.1 Mustang Bio Company Details
  • 13.10.2 Mustang Bio Business Overview and Its Total Revenue
  • 13.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
  • 13.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 13.10.5 Mustang Bio Recent Development
• 13.11 CARsgen Therapeutics
  • 10.11.1 CARsgen Therapeutics Company Details
  • 10.11.2 CARsgen Therapeutics Business Overview and Its Total Revenue
  • 10.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
  • 10.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 10.11.5 CARsgen Therapeutics Recent Development
• 13.12 Xyphos
  • 10.12.1 Xyphos Company Details
  • 10.12.2 Xyphos Business Overview and Its Total Revenue
  • 10.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
  • 10.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 10.12.5 Xyphos Recent Development
• 13.13 Minerva Biotechnologies
  • 10.13.1 Minerva Biotechnologies Company Details
  • 10.13.2 Minerva Biotechnologies Business Overview and Its Total Revenue
  • 10.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
  • 10.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 10.13.5 Minerva Biotechnologies Recent Development
• 13.14 Adaptimmune
  • 10.14.1 Adaptimmune Company Details
  • 10.14.2 Adaptimmune Business Overview and Its Total Revenue
  • 10.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
  • 10.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 10.14.5 Adaptimmune Recent Development
• 13.15 Ziopharm Oncology
  • 10.15.1 Ziopharm Oncology Company Details
  • 10.15.2 Ziopharm Oncology Business Overview and Its Total Revenue
  • 10.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
  • 10.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 10.15.5 Ziopharm Oncology Recent Development
• 13.16 Aurora Biopharma
  • 10.16.1 Aurora Biopharma Company Details
  • 10.16.2 Aurora Biopharma Business Overview and Its Total Revenue
  • 10.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
  • 10.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 10.16.5 Aurora Biopharma Recent Development
• 13.17 Creative Biolabs
  • 10.17.1 Creative Biolabs Company Details
  • 10.17.2 Creative Biolabs Business Overview and Its Total Revenue
  • 10.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
  • 10.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  • 10.17.5 Creative Biolabs Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer